However, loss of nuclear ATRX expression is easily detectable by immunohistochemistry to distinguish IDH-mutant astrocytomas from IDH-mutant and 1p/19q-codeleted oligodendrogliomas [46, 47]. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).